| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 成品药销售(元) | 2,793,162,762.94 | 5,758,583,175.51 | 3,145,772,812.64 |
| 技术服务(元) | 27,782,801.38 | 62,884,859.94 | 45,194,995.35 |
| 进出口贸易(元) | - | - | 2,576,305.01 |
| 原料药及中间体销售(元) | 1,659,373,721.32 | 3,646,406,843.71 | 1,893,312,997.73 |
| 其他(元) | 35,132,079.88 | 77,689,301.54 | 41,126,360.07 |
| 营业成本(元) | |||
| 成品药销售(元) | 792,276,439.83 | 1,637,587,902.79 | 948,073,012.47 |
| 技术服务(元) | 5,413,533.63 | 34,626,809.95 | 13,683,431.80 |
| 进出口贸易(元) | - | - | 2,510,868.94 |
| 原料药及中间体销售(元) | 840,114,056.53 | 1,918,546,115.27 | 959,340,406.83 |
| 其他(元) | 18,438,571.40 | 44,768,533.65 | 24,567,627.66 |
| 毛利(元) | |||
| 成品药销售(元) | 2,000,886,323.11 | 4,120,995,272.72 | 2,197,699,800.17 |
| 技术服务(元) | 22,369,267.75 | 28,258,049.99 | 31,511,563.55 |
| 进出口贸易(元) | - | - | 65,436.07 |
| 原料药及中间体销售(元) | 819,259,664.79 | 1,727,860,728.44 | 933,972,590.90 |
| 其他(元) | 16,693,508.48 | 32,920,767.89 | 16,558,732.41 |
| 毛利率(%) | |||
| 成品药销售(%) | 71.64 | 71.56 | 69.86 |
| 技术服务(%) | 80.51 | 44.94 | 69.72 |
| 进出口贸易(%) | - | - | 2.54 |
| 原料药及中间体销售(%) | 49.37 | 47.39 | 49.33 |
| 其他(%) | 47.52 | 42.37 | 40.26 |
| 收入构成(%) | |||
| 成品药销售(%) | 61.86 | 60.33 | 61.35 |
| 技术服务(%) | 0.62 | 0.66 | 0.88 |
| 进出口贸易(%) | - | - | 0.05 |
| 原料药及中间体销售(%) | 36.75 | 38.20 | 36.92 |
| 其他(%) | 0.78 | 0.81 | 0.80 |
| 毛利构成(%) | |||
| 成品药销售(%) | 69.98 | 69.73 | 69.11 |
| 技术服务(%) | 0.78 | 0.48 | 0.99 |
| 进出口贸易(%) | - | - | 0.00 |
| 原料药及中间体销售(%) | 28.65 | 29.24 | 29.37 |
| 其他(%) | 0.58 | 0.56 | 0.52 |